Perceptive Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Perceptive Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,100,000	Closed	-$134M	–	127
2025 Q4	$134M	Buy	+1,100,000	New	+$126M	2.39%	9
2025 Q3	–	Sell	-300,000	Closed	-$24.9M	–	103
2025 Q2	$24.9M	Buy	+300,000	New	+$23.9M	0.92%	27
2024 Q4	–	Sell	-400,000	Closed	-$39.5M	–	122
2024 Q3	$39.5M	Buy	+400,000	New	+$39.3M	0.84%	33
2024 Q2	–	Sell	-50,000	Closed	-$4.74M	–	129
2024 Q1	$4.74M	Sell	50,000 -1,850,000	-97%	-$172M	0.08%	89
2023 Q4	$1.28M	Buy	+1,900,000	New	+$141M	0.03%	91
2023 Q3	–	Sell	-150,000	Closed	-$138K	–	107
2023 Q2	$138K	Buy	150,000 +50,000	+50%	+$4.18M	﹤0.01%	89
2023 Q1	$7.62M	Buy	+100,000	New	+$8.3M	0.23%	71
2022 Q3	–	Sell	-100,000	Closed	-$7.43M	–	125
2022 Q2	$7.43M	Buy	+100,000	New	+$7.51M	0.23%	71
2021 Q1	–	Sell	-200,000	Closed	-$28.2M	–	164
2020 Q4	$28.2M	Hold	200,000	–	–	0.3%	67
2020 Q3	$22.3M	Buy	+200,000	New	+$22.4M	0.33%	63
2020 Q1	–	Sell	-1,000,000	Closed	-$1.56M	–	126
2019 Q4	$1.56M	Buy	1,000,000 +100,000	+11%	+$8.65M	0.03%	90
2019 Q3	$1.6M	Buy	900,000 +700,000	+350%	+$58.2M	0.04%	83
2019 Q2	$70K	Buy	+200,000	New	+$17.1M	﹤0.01%	101
2018 Q2	–	Sell	-900,000	Closed	-$1.55M	–	148
2018 Q1	$1.55M	Buy	900,000 +300,000	+50%	+$27.4M	0.04%	98
2017 Q4	$579K	Buy	+600,000	New	+$50.3M	0.02%	117
2016 Q3	–	Sell	-500,000	Closed	-$27M	–	218
2016 Q2	$27M	Buy	+500,000	New	+$27.4M	1.87%	13
2015 Q4	–	Sell	-275,000	Closed	-$17.1M	–	175
2015 Q3	$17.1M	Sell	275,000 -175,000	-39%	-$13.8M	1.37%	18
2015 Q2	$37.8M	Buy	+450,000	New	+$35M	2.28%	9

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Perceptive Advisors's XBI Position: Q3 2024 in Review

Perceptive Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2024, closing a stake of 22,665 shares — an estimated $2.23M sold.

Perceptive Advisors first reported a position in XBI in Q4 2016 and held it in 2 quarters. The position peaked at $2.1M in Q2 2024. 769 funds tracked by Wall St. Rank hold XBI as of Q3 2024.

Perceptive Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2024 after selling out during the quarter.
Perceptive Advisors sold 22,665 State Street SPDR S&P Biotech ETF shares in Q3 2024, an estimated $2.23M.
Perceptive Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2016 and held it in 2 quarters.
Perceptive Advisors's State Street SPDR S&P Biotech ETF position peaked at $2.1M in Q2 2024.
769 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2024.

Based on Perceptive Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.